UBS Upgrades Scotts Miracle Gro to Buy, Lowers Price Target to $70

Benzinga · 3d ago
UBS analyst Peter Grom upgrades Scotts Miracle Gro (NYSE:SMG) from Neutral to Buy and lowers the price target from $78 to $70.